TipRanks
Go Ultimate55% OFF

Sinopharm Group Co (X2S1) Balance Sheet

Sinopharm Group Co Balance Sheet

Sinopharm Group Co's total assets for Q2 2026 were $404.57B, an increase of 3.57% from the previous quarter. DE:X2S1 total liabilities were $268.18B for the fiscal quarter, a 4.61% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 390.61B$ 392.83B$ 383.39B$ 364.78B$ 335.41B
$ 256.36B$ 266.14B$ 263.08B$ 254.71B$ 235.76B
$ 134.25B$ 126.69B$ 120.32B$ 110.07B$ 99.65B

Currency in CNY

Sinopharm Group Co Debt to Assets

0150B300B450B65 %67.5 %70 %72.5 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets